Whittaker, D. S., Wang, H., Loh, D. H., Cachope, R., & Colwell, C. S. (2017). Possible use of a H3R antagonist for the management of nonmotor symptoms in the Q175 mouse model of Huntington's disease. Pharmacol Res Perspect.

Whittaker, Daniel S., Huei‐Bin Wang, Dawn H. Loh, Roger Cachope, and Christopher S. Colwell. "Possible Use of a H3R Antagonist for the Management of Nonmotor Symptoms in the Q175 Mouse Model of Huntington's Disease." Pharmacol Res Perspect 2017.

Whittaker, Daniel S., et al. "Possible Use of a H3R Antagonist for the Management of Nonmotor Symptoms in the Q175 Mouse Model of Huntington's Disease." Pharmacol Res Perspect 2017.